Literature DB >> 15684118

Glycogen storage disease type III in Inuit children.

Paul James A Zimakas1, Celia J Rodd.   

Abstract

Glycogen storage disease type III (GSD III) was diagnosed in 4 Inuit children (3 confirmed, 1 suspected case) at our institution over the last decade. This rare autosomal recessive disease, which results from a deficiency of the debranching enzyme required for complete degradation of the glycogen molecule, has not been previously described in this population. The possible clinical presentations are heterogeneous, as is the spectrum of severity of this disease. The long-term sequelae can be severe, including recurrent hypoglycemia, hepatic cirrhosis and progressive muscle weakness. These 4 cases would suggest an increased prevalence of GSD III in the Inuit population. Therefore, it is important for health care providers caring for this population to consider and recognize this rare but serious disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15684118      PMCID: PMC545759          DOI: 10.1503/cmaj.1031589

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  12 in total

1.  Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma. The Liver Transplant Group.

Authors:  E B Haagsma; G P Smit; K E Niezen-Koning; A S Gouw; L Meerman; M J Slooff
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

2.  Cardiac involvement in glycogen storage disease type III.

Authors:  S W Moses; K L Wanderman; A Myroz; M Frydman
Journal:  Eur J Pediatr       Date:  1989-08       Impact factor: 3.183

3.  A single and early migration for the peopling of the Americas supported by mitochondrial DNA sequence data.

Authors:  S L Bonatto; F M Salzano
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

4.  A single-base deletion in the 3'-coding region of glycogen-debranching enzyme is prevalent in glycogen storage disease type IIIA in a population of North African Jewish patients.

Authors:  R Parvari; S Moses; J Shen; E Hershkovitz; A Lerner; Y T Chen
Journal:  Eur J Hum Genet       Date:  1997 Sep-Oct       Impact factor: 4.246

5.  Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease.

Authors:  M Siciliano; E De Candia; S Ballarin; F M Vecchio; S Servidei; R Annese; R Landolfi; L Rossi
Journal:  J Clin Gastroenterol       Date:  2000-07       Impact factor: 3.062

Review 6.  Molecular characterization of glycogen storage disease type III.

Authors:  J J Shen; Y T Chen
Journal:  Curr Mol Med       Date:  2002-03       Impact factor: 2.222

Review 7.  Glycogen storage diseases. Phenotypic, genetic, and biochemical characteristics, and therapy.

Authors:  J I Wolfsdorf; I A Holm; D A Weinstein
Journal:  Endocrinol Metab Clin North Am       Date:  1999-12       Impact factor: 4.741

Review 8.  Liver transplantation for glycogen storage disease types I, III, and IV.

Authors:  D Matern; T E Starzl; W Arnaout; J Barnard; J S Bynon; A Dhawan; J Emond; E B Haagsma; G Hug; A Lachaux; G P Smit; Y T Chen
Journal:  Eur J Pediatr       Date:  1999-12       Impact factor: 3.183

9.  Type III glycogen storage disease: an adult case with mild disease but complete absence of debrancher protein.

Authors:  B Z Yang; C Stewart; J H Ding; Y T Chen
Journal:  Neuromuscul Disord       Date:  1991       Impact factor: 4.296

10.  Glycogen debranching enzyme deficiency: long-term study of serum enzyme activities and clinical features.

Authors:  R A Coleman; H S Winter; B Wolf; Y T Chen
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

View more
  4 in total

1.  Old meets new: identifying founder mutations in genetic disease.

Authors:  Jane A Evans
Journal:  CMAJ       Date:  2015-01-19       Impact factor: 8.262

2.  Markedly elevated serum transaminases in glycogen storage disease type III.

Authors:  Christine Karwowski; Csaba Galambos; David Finegold; Benjamin L Shneider
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-05       Impact factor: 2.839

3.  A founder AGL mutation causing glycogen storage disease type IIIa in Inuit identified through whole-exome sequencing: a case series.

Authors:  Isabelle Rousseau-Nepton; Minoru Okubo; Rosemarie Grabs; John Mitchell; Constantin Polychronakos; Celia Rodd
Journal:  CMAJ       Date:  2015-01-19       Impact factor: 8.262

Review 4.  A decade of research in Inuit children, youth, and maternal health in Canada: areas of concentrations and scarcities.

Authors:  Amanda J Sheppard; Ross Hetherington
Journal:  Int J Circumpolar Health       Date:  2012-07-26       Impact factor: 1.228

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.